Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 49251-49300 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06393179
Epidemiology and Treatment Strategy of Open Respiratory Phenotype in Critically Ill Patients
NARecruiting
60 participants
Started: May 30, 2024 · Completed: Aug 30, 2024
2 conditions1 sponsor1 location
NCT06445244
α-ketoglutarate in Patients With Hypertension
NARecruiting
30 participants
Started: May 30, 2024 · Completed: Aug 31, 2024
1 condition1 sponsor1 location
NCT06415383
The Effects of Vitamin B6 Supplementation on Pain Thresholds and Tolerance
PHASE1Recruiting
20 participants
Started: May 30, 2024 · Completed: Mar 31, 2025
1 condition2 sponsors1 location
NCT06440759
To Compare the Efficacy and Safety of Using oXiris and M100 During CRRT
NARecruiting
60 participants
Started: May 30, 2024 · Completed: May 1, 2026
2 conditions1 sponsor1 location
NCT06436612
Study of Magnetic Resonance Image and Computed Tomography-Guided Stereotactic Body Radiation Therapy for Abdominopelvic Sarcomas (MARS Trial)
PHASE2Recruiting
20 participants
Started: May 30, 2024 · Completed: May 26, 2028
1 condition1 sponsor1 location
NCT04744675
Peripheral Nerve Injections for CRPS
PHASE2Active, not recruiting
50 participants
Started: May 30, 2024 · Completed: Jun 30, 2025
1 condition1 sponsor2 locations
NCT06444035
Extended Therapeutic Effect of 35kDa Hyaluronan Fragment Injection in Patients With Chronic Pain Caused by Myofascial Pain Syndrome
NAEnrolling by invitation
10 participants
Started: May 30, 2024 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT06455228
Long Peripheral Intravenous Catheter Insertion Site and Catheter-related Complications in Antimicrobial Therapy
NARecruiting
90 participants
Started: May 30, 2024 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06412536
Triage Survey for Cardiovascular, Obesity, and Related Endocrine Trial Eligibility
N/ARecruiting
10,000 participants
Started: May 30, 2024 · Completed: Apr 17, 2029
5 conditions1 sponsor1 location
NCT06372626
Study of ZG005 in Combination With Etoposide and Cisplatin in Participants With Advanced Neuroendocrine Carcinoma.
PHASE1/PHASE2Recruiting
93 participants
Started: May 30, 2024 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT06483685
Radiopharmaceuticals Analysis for Detailed Insights And INternational Tracking of Safety
N/AActive, not recruiting
500,000 participants
Started: May 30, 2024 · Completed: Aug 1, 2024
2 conditions1 sponsor1 location
NCT06441578
A Survey of Recombinant ADAMTS13 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
N/ARecruiting
40 participants
Started: May 30, 2024 · Completed: Sep 30, 2032
1 condition1 sponsor1 location
NCT05935241
mPATH for Low-income Older Adults
NARecruiting
176 participants
Started: May 30, 2024 · Completed: Dec 31, 2029
3 conditions2 sponsors1 location
NCT06458699
Management Of Stoma In Patients Younger Than 3 Months Old
N/AActive, not recruiting
82 participants
Started: May 30, 2024 · Completed: Jul 15, 2024
3 conditions1 sponsor1 location
NCT06464978
Stapler Reinforcement Patches Compared to Standard Staplers in Gastrojejunostomy
NARecruiting
382 participants
Started: May 30, 2024 · Completed: Jun 30, 2026
4 conditions6 sponsors1 location
NCT06946940
Biosignature of the Response to Treatment With Cannabis Oil in Individuals With Fibromyalgia
PHASE2Recruiting
150 participants
Started: May 30, 2024 · Completed: May 31, 2027
1 condition2 sponsors1 location
NCT06417983
Topical Application of Essential Oils to Treat Onchomycosis
N/ANot yet recruiting
50 participants
Started: May 30, 2024 · Completed: Nov 1, 2024
3 conditions1 sponsor0 locations
NCT06448169
Observational Study on the Sensitivity of Neoadjuvant Immunotherapy in Early Triple-Negative Breast Cancer
N/ANot yet recruiting
200 participants
Started: May 30, 2024 · Completed: Apr 30, 2026
3 conditions2 sponsors0 locations
NCT05963074
A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia
PHASE2Recruiting
320 participants
Started: May 30, 2024 · Completed: Mar 19, 2029
2 conditions2 sponsors74 locations
NCT06399172
OncoSil Pancreatic Cancer Post-marketing Clinical Registry - Italy
N/ANot yet recruiting
50 participants
Started: May 30, 2024 · Completed: Oct 30, 2029
1 condition1 sponsor0 locations
NCT06438627
Efficacy and Safety of TPC+Apatinib+Camrelizumab vs GP+ Camrelizumab for High-Risk Nasopharyngeal Carcinoma: A Phase 3 Trial
PHASE3Recruiting
164 participants
Started: May 30, 2024 · Completed: May 30, 2029
1 condition1 sponsor2 locations
NCT06306716
A Clinical Study on New Negative Pressure Wound Therapy Dressing in the Management of Chronic & Acute Wounds
N/ARecruiting
42 participants
Started: May 30, 2024 · Completed: Mar 31, 2026
2 conditions1 sponsor2 locations
NCT06722456
Assessment of Non-invasive Tools for Detecting Active Inflammatory Bowel Disease
N/AEnrolling by invitation
120 participants
Started: May 30, 2024 · Completed: Dec 15, 2025
3 conditions1 sponsor1 location
NCT05151211
Use of 1 Minute Sit to Stand Test for Physical Capacity and Effort Related Desaturation in Amyotrophic Lateral Sclerosis
N/ANot yet recruiting
35 participants
Started: May 30, 2024 · Completed: Mar 1, 2025
1 condition1 sponsor1 location
NCT06428500
QTX3046 in Patients With KRAS G12D Mutations
PHASE1Active, not recruiting
240 participants
Started: May 30, 2024 · Completed: Jul 1, 2027
1 condition1 sponsor5 locations
NCT06393673
A Study to Find the Best Dose of HS-10384 to Treat Vasomotor Symptoms in Postmenopausal Women
PHASE2Not yet recruiting
195 participants
Started: May 30, 2024 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT06367374
MRD Guided Sonrotoclax and Zanubrutinib in Newly Diagnosed CLL/SLL
PHASE2Not yet recruiting
66 participants
Started: May 30, 2024 · Completed: Jul 30, 2030
2 conditions1 sponsor0 locations
NCT06320080
Clinical Study of TQB2223 Injection Combined With AK105 Injection in the Treatment of Advanced Hepatocellular Carcinoma.
PHASE1Recruiting
34 participants
Started: May 30, 2024 · Completed: Oct 31, 2025
1 condition1 sponsor3 locations
NCT06432127
Role of Ultrasound Guide Greater Occipital Nerve Block at Second Cervical Vertebra in Migraine Headache Prophylaxis
PHASE4Not yet recruiting
108 participants
Started: May 30, 2024 · Completed: Jan 31, 2027
1 condition1 sponsor1 location
NCT06411288
Global Study of Del-desiran for the Treatment of DM1
PHASE3Active, not recruiting
159 participants
Started: May 30, 2024 · Completed: Sep 30, 2026
10 conditions1 sponsor34 locations
NCT06426758
Graves' Disease Induced by Epstein-Barr Virus Lytic Reactivation
N/ANot yet recruiting
300 participants
Started: May 30, 2024 · Completed: Sep 1, 2027
3 conditions2 sponsors1 location
NCT05969457
Effect of Preventive Analgesia by Injection of a Local Anesthetic Before Vaginal Incision for Hysterectomy by vNOTES Approach
PHASE3Not yet recruiting
108 participants
Started: May 30, 2024 · Completed: Oct 1, 2027
1 condition2 sponsors0 locations
NCT06425978
Efficacy of the Use of Cellular Matrix/ A-CP-HA Kit
PHASE4Recruiting
192 participants
Started: May 30, 2024 · Completed: Aug 31, 2026
1 condition2 sponsors1 location
NCT06449885
A Cohort Study in Newly Diagnosed MZL
N/ARecruiting
2,500 participants
Started: May 30, 2024 · Completed: Jun 30, 2034
1 condition1 sponsor1 location
NCT06918860
Analysis of Intramedullary Nail and Prosthetic Reconstruction After Surgical Treatment of Bone Metastases of Proximal Femur
N/ARecruiting
600 participants
Started: May 30, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06345534
FAST-FORWARD vs HAI5
NARecruiting
740 participants
Started: May 30, 2024 · Completed: Dec 31, 2033
1 condition1 sponsor2 locations
NCT06422117
Efficacy and Safety of HSK16149 Capsule in the Treatment of Moderate and Severe Central Neuropathic Pain in China
PHASE3Not yet recruiting
408 participants
Started: May 30, 2024 · Completed: Aug 7, 2027
1 condition1 sponsor0 locations
NCT06417606
Lenvatinib and Adebrelimab Combined With GEMOX in the Perioperative Treatment of Potentially Resectable Intrahepatic Cholangiocarcinoma
PHASE4Not yet recruiting
20 participants
Started: May 30, 2024 · Completed: May 30, 2025
1 condition1 sponsor1 location
NCT06419569
Efficacy of High Power Laser Versus Low Level Laser in Ultrasonographic and Functional Outcomes in Patients With Knee Osteoarthritis
NANot yet recruiting
90 participants
Started: May 30, 2024 · Completed: Dec 15, 2024
1 condition1 sponsor0 locations
NCT06831279
Comparison of Two Different Rehabilitation Approaches Applied After Anterior Cruciate Ligament Reconstruction
NARecruiting
40 participants
Started: May 30, 2024 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05526963
Reduction of Polypharmacy in Elderly People With Multiple Diseases
NARecruiting
1,146 participants
Started: May 30, 2024 · Completed: Dec 31, 2025
2 conditions3 sponsors1 location
NCT06409962
A New Technological Intervention to Address Childhood Obesity:
NARecruiting
215 participants
Started: May 30, 2024 · Completed: Dec 31, 2026
3 conditions2 sponsors1 location
NCT06419751
the Effects of Different Exercise on Vascular Health
NANot yet recruiting
216 participants
Started: May 30, 2024 · Completed: Jun 30, 2025
4 conditions1 sponsor0 locations
NCT06337084
Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors
PHASE1Recruiting
12 participants
Started: May 30, 2024 · Completed: Apr 30, 2026
9 conditions1 sponsor1 location
NCT06426485
To Evaluate the Long-term Efficacy and Safety of Toludevenlafaxine Hydrochloride Sustained-release Tablets
PHASE4Not yet recruiting
736 participants
Started: May 30, 2024 · Completed: Jun 30, 2027
1 condition1 sponsor0 locations
NCT06414525
Effect of Abdominal Massage Versus Visceral Manipulation on Constipation
NARecruiting
75 participants
Started: May 30, 2024 · Completed: Aug 31, 2024
1 condition1 sponsor1 location
NCT05804370
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
PHASE3Recruiting
170 participants
Started: May 30, 2024 · Completed: May 31, 2027
1 condition1 sponsor6 locations
NCT06419101
Exploring the Diagnostic Biomarkers of Cognitive Disorders in China
N/ARecruiting
3,000 participants
Started: May 30, 2024 · Completed: May 10, 2035
2 conditions5 sponsors1 location
NCT06667622
Sodium Glycididazole Reduces the Adverse Reactions of Concurrent Chemoradiotherapy
PHASE2Recruiting
40 participants
Started: May 29, 2024 · Completed: Jul 20, 2026
1 condition1 sponsor1 location
NCT07142681
Changes in the Dietary Patterns of Adults in Care of a Newly Diagnosed Type 1 Diabetes Mellitus Child
N/ARecruiting
26 participants
Started: May 29, 2024 · Completed: May 31, 2027
3 conditions4 sponsors1 location